SCHEMBL3379216

SCHEMBL3379216

CC(C)(C)/C=C/C(=O)c1ccsc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
GPR52 Q9Y2T5 1/20 0.48
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
DAO P14920 1/20 0.47
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HDAC1 Q13547 1/20 0.43
KDR P35968 3/20 0.42
HPGD P15428 2/20 0.38
ALDH1A1 P00352 2/20 0.34
PKM P14618 2/20 0.34
HTT P42858 2/20 0.34
ATM Q13315 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
NLRP1 Q9C000 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
NTSR1 P30989 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3379219 1.00 CES2 (0.48) CES2CES1GPR52LCKFYN
SCHEMBL2210238 0.75 RECQL (0.58) CES2CES1GPR52LCKFYN
SCHEMBL2210233 0.75 RECQL (0.58) CES2CES1GPR52LCKFYN
SCHEMBL6050171 0.75
SCHEMBL10033941 0.73 RECQL (0.55) GPR52NPC1RAB9AHPGDALDH1A1
SCHEMBL11028515 0.73 RECQL (0.55) GPR52NPC1RAB9AHPGDALDH1A1
SCHEMBL23117785 0.73 GUSB (0.56) CES2CES1GPR52LCKFYN
SCHEMBL7493836 0.72
SCHEMBL10425 0.72
SCHEMBL28587407 0.71 CES2 (0.48) CES2CES1GPR52LCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO disclosed